Welcome to the Canadian Society for Pharmaceutical Sciences
As the recently elected president of CSPS, it is my pleasure to have the opportunity to communicate to you via our rather recently created website. While it has been serving its purpose well, it is still a work in progress and we would welcome your comments and thoughts on how we might further improve the website. Please feel free to contact us at any time.
Unlike our past president, Dr. Frank Abbott, who has been a founding member of CSPS since its inception, I was more an outsider, attracted to the society by its novel mission and vision and was truly honored to be nominated to the president-elect position two years ago and now president of the CSPS Board of Directors. The organization, currently in its twenty-first year of operation, has demonstrated a great track record in fulfilling its mandate of pursuing excellence in pharmaceutical sciences research and training.
To help achieve this end, CSPS, acting as the prime organization in Canada to bring together researchers and trainees from academia, industry and government, effectively facilitated several key workshops on Biosimilars and Biowaivers. In addition to showcasing the core drug discovery and effective drug development programs of pharmaceuticals in Canada, the CSPS 2017 conference in Montreal also featured the new frontier of Immuno-Oncology and Translational Medicine. The annual CSPS Conference, CSPS workshops, plus networking and educational events continue to serve as excellent venues to forge fruitful partnerships to accomplish these goals.
Coming soon is the 2018 CSPS Conference to be held in Toronto, ON from May 22 to May 25 with the theme of “Translating Innovative Technology to Patient Care”. The first day of presentation is dedicated to exciting discoveries and innovation within the Bio-pharmaceutical industry including presentations from the smaller biotech start-up companies. Back by popular demands would be last year’s Immuno Oncology (IO) and Translational Medicine sessions. The IO session in 2018 conference, chaired by Dr. Pam Ohashi, would be featuring CAR T Cell therapy and check point proteins as novel and life-saving cancer treatments. The fate and destiny of pharmaceutical business in Canada can potentially be impacted by Regulatory Reforms taking place in the next few years, these would include Drug Approvals, Reimbursement and Pricing. Leading this very important discussion affecting every Canadian is Cathy Parker, head of the Biologic Division of Health Canada. Other important core programs include Opioids, Cannabis, and Pharmacogenomics. We have many excellent speakers confirmed for this conference. Please join us in the Toronto area to make this one of our more successful annual conferences.
CSPS has an exemplary and prestigious awards program and the annual conference serves as the ideal platform to celebrate those who have made outstanding contributions to the pharmaceutical sciences. Please take the opportunity now to nominate individuals that you consider to be deserving candidates for these awards.
I would like to thank all our sponsors, committee members and board directors for your dedication and unwavering support of CSPS activities. I would also like to acknowledge all our long and short term registered members who have over the years provided comments and suggestions to the society and we hope to hear more from you.
All the best in 2018 and see you at the conference in May!
Catherine Lau, Ph.D.
President, CSPS, and
Vice-President – Regulatory Affairs & Quality Management, Janssen Inc.